SECTOR INTELLIGENCE
Congressional activity related to healthcare policy, pharmaceutical regulation, and Medicare/Medicaid changes. AI-analyzed for market impact.
In FY2024, the U.S. government awarded $773.68 billion in contracts — $464 billion to defense alone. Lockheed Martin got $50.7B. This data is public, updated daily, and most investors ignore it entirely.
9 min readStrategyCongressional leaders outperform backbenchers by up to 47% annually (NBER, 2025). Bloomberg Government costs $8K+/year. The underlying data is free — here's how to actually use it.
10 min readThis $14.1B Medicaid block grant to the Minnesota Department of Human Services is a routine renewal under the federal-state Medicaid entitlement program. As a state government recipient, there is no direct benefit to any publicly traded company, and no stock market impact is expected.
This $1.4B block grant to the Texas Health and Human Services Commission is a routine Medicaid entitlement renewal for FY 2026. Because the recipient is a state agency, there is no direct impact on publicly traded companies, though the broader healthcare sector may see indirect effects from ongoing Medicaid funding stability.
This $3.5B block grant to the District of Columbia government under the Centers for Medicare and Medicaid Services funds Medicaid entitlement for FY2026. It is a routine state-level transfer with no direct impact on publicly traded companies.
This is a $8.2B block grant from CMS to the Oklahoma Health Care Authority for Medicaid entitlement, but the recipient is a private state agency, not a publicly-traded company. No direct stock market impact is attributable.
This is a $2.0 billion Medicaid block grant renewal to the State of Montana Department of Health and Human Services for FY 2026. As the recipient is a state government entity, there are no directly impacted publicly traded companies. The award reinforces ongoing federal healthcare entitlement spending but does not create new corporate revenue streams.
This is a $1.7B block grant to the New Hampshire Department of Health & Human Services for Medicaid entitlement—a routine state-level funding renewal. No publicly-traded company receives this award, so there is no direct stock market catalyst.
This $15.1B block grant is a routine Medicaid entitlement renewal for Missouri's Department of Social Services for FY2026, awarded by CMS. As the recipient is a state agency, there is no direct public company beneficiary, and the contract reflects ongoing federal healthcare funding rather than a competitive award.
The $1.1B block grant to North Dakota's Department of Human Services funds Medicaid entitlement for FY2026. While not directly benefiting any publicly traded company, the award signals sustained federal support for state Medicaid programs, which underpins revenue for healthcare providers and managed care organizations serving Medicaid populations.
The Alabama Medicaid Agency received a $6.6B block grant from CMS for FY2026 Medicaid entitlement services. As the recipient is a state government entity, no public company is directly awarded. The contract reinforces ongoing federal healthcare spending but does not create new catalysts for specific publicly traded firms.
This is a $1.4 billion Medicaid block grant to the Vermont Agency of Human Services for FY2026. As a state government recipient, it does not directly benefit any publicly-traded company. The grant funds healthcare services for low-income residents and is a routine annual appropriation.
Get AI-analyzed alerts for healthcare policy, pharmaceutical regulation, and Medicare/Medicaid changes.
Get Started →